Requisites for successful theranostics with radionuclide-based reporter gene imaging

References

• Bhaumik S. Advances in imaging gene-directed enzyme prodrug therapy. Curr Pharm Biotechnol 2011;12:497–507
   PubMed Web of Science ®Google Scholar
• Ahn BC. Applications of molecular imaging in drug discovery and development process. Curr Pharm Biotechnol 2011;12:459–68
   PubMed Web of Science ®Google Scholar
• Ray P, De A. Reporter gene imaging in therapy and diagnosis. Theranostics 2012;2:333–4
   PubMedGoogle Scholar
• Kang JH, Chung JK. Molecular-genetic imaging based on reporter gene expression. J Nucl Med 2008;49:164S–79S
   PubMed Web of Science ®Google Scholar
• Ahn BC, Ronald JA, Kim YI, et al. Potent, tumor-specific gene expression in an orthotopic hepatoma rat model using a Survivin-targeted, amplifiable adenoviral vector. Gene Ther 2011;18:606–12
   PubMed Web of Science ®Google Scholar
• Seo JH, Jeon YH, Lee YJ, et al. Trafficking macrophage migration using reporter gene imaging with human sodium iodide symporter in animal models of inflammation. J Nucl Med 2010;51:1637–43
   PubMed Web of Science ®Google Scholar
• Jeon YH, Lee HW, Lee YL, et al. Combined E7-dendritic cell-based immunotherapy and human sodium/iodide symporter radioiodine gene therapy with monitoring of antitumor effects by bioluminescent imaging in a mouse model of uterine cervical cancer. Cancer Biother Radiopharm 2011;26:671–9
   PubMed Web of Science ®Google Scholar
• Yaghoubi SS, Campbell DO, Radu CG, Czernin J. Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications. Theranostics 2012;2:374–91
   PubMed Web of Science ®Google Scholar
• Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature 2008;452:580–9
   PubMed Web of Science ®Google Scholar
• Ahn BC. Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and back. Theranostics 2012;2:392–402
   PubMedGoogle Scholar
• Sosnovik DE, Wu JC. Molecular imaging of stem cells in myocardial infarction. Shelton: PMPH-USA; 2010
   Google Scholar
• Robson T, Hirst DG. Transcriptional targeting in cancer gene therapy. J Biomed Biotechnol 2003;2003:110–37
   Google Scholar
• Schuldiner M, Itskovitz-Eldor J, Benvenisty N. Selective ablation of human embryonic stem cells expressing a “suicide” gene. Stem Cells 2003;21:257–65
   PubMed Web of Science ®Google Scholar
• Knoepfler PS. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 2009;27:1050–6
   PubMed Web of Science ®Google Scholar
• Cao F, Lin S, Xie X, et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 2006;113:1005–14
   PubMed Web of Science ®Google Scholar
• Ziessman HA, O'Malley JP, Thrall JH. Nuclear medicine: the requisites in radiology. Philadelphia (PA): Elsevier Mosby; 2006
   Google Scholar
• Hamoudeh M, Kamleh MA, Diab R, Fessi H. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer. Adv Drug Deliv Rev 2008;60:1329–46
   PubMed Web of Science ®Google Scholar
• Sgouros G. Alpha-particles for targeted therapy. Adv Drug Deliv Rev 2008;60:1402–6
   PubMed Web of Science ®Google Scholar
• Srivastava SC. The role of electron-emitting radiopharmaceuticals in the palliative treatment of metastatic bone pain and for radiosynovectomy: applications of conversion electron emitter Tin-117m. Brazilian Arch Biol Technol 2007;50:49–62
   Web of Science ®Google Scholar
• Limouris GS, Chatziioannou A, Kontogeorgakos D, et al. Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases. Eur J Nucl Med Mol Imaging 2008;35:1827–37
   PubMed Web of Science ®Google Scholar
• Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167–214
   PubMed Web of Science ®Google Scholar
• Bhang HE, Pomper MG. Cancer imaging: gene transcription-based imaging and therapeutic systems. Int J Biochem Cell Biol 2012;44:684–9
   PubMed Web of Science ®Google Scholar
• Fang B, Roth J. Adenovector-mediated cancer gene therapy. Totowa: Humana Press Inc.; 2007
   Google Scholar
• Kamimura K, Suda T, Zhang G, Liu D. Advances in gene delivery systems. Pharmaceut Med 2011;25:293–306
   PubMedGoogle Scholar
• Duarte S, Carle G, Faneca H, et al. Suicide gene therapy in cancer: where do we stand now? Cancer Lett 2012;324:160–70
   PubMed Web of Science ®Google Scholar
• Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003;4:346–58
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Curiel DT. Tumor targeting – retargeted adenovirus. Totowa: Humana Press; 2007
   Google Scholar
• Douglas JT, Rogers BE, Rosenfeld ME, et al. Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol 1996;14:1574–8
   PubMed Web of Science ®Google Scholar
• Witlox MA, Lamfers ML, Wuisman PI, et al. Evolving gene therapy approaches for osteosarcoma using viral vectors: review. Bone 2007;40:797–812
   PubMed Web of Science ®Google Scholar
• Lee P, Huang L. Nonviral vector systems. Totowa: Humana Press Inc.; 2007
   Google Scholar
• Nimesh S. Potential implications of nanoparticle characterization on in vitro and in vivo gene delivery. Ther Deliv 2012;3:1347–56
   PubMedGoogle Scholar
• Ogris M, Wagner E. Targeting tumors with non-viral gene delivery systems. Drug Discov Today 2002;7:479–85
   PubMed Web of Science ®Google Scholar
• Cho K, Wang X, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008;14:1310–16
   PubMed Web of Science ®Google Scholar
• Walker GF, Wagner E. Nonviral vector systems for cancer gene therapy. Totowa: Humana Press; 2005
   Google Scholar
• Kim KI, Lee YJ, Lee TS, et al. In vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression. Nucl Med Mol Imaging 2013;7:1–8
   Google Scholar
• Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nature reviews. Genetics 2011;12:283–93
   PubMed Web of Science ®Google Scholar
• Dorer DE, Nettelbeck DM. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Adv Drug Deliv Rev 2009;61:554–71
   PubMed Web of Science ®Google Scholar
• Ray S, Paulmurugan R, Patel MR, et al. Noninvasive imaging of therapeutic gene expression using a bidirectional transcriptional amplification strategy. Mol Ther 2008;16:1848–56
   PubMed Web of Science ®Google Scholar
• Ray P, Gambhir SS. Multimodality imaging of reporter genes. In: Gambhir SS, Yaghoubi SS, eds. Molecular imaging with reporter genes. NY: Cambridge University Press; 2010:113–26
   Google Scholar
• Waerzeggers Y, Monfared P, Viel T, et al. Methods to monitor gene therapy with molecular imaging. Methods 2009;48:146–60
   PubMed Web of Science ®Google Scholar
• Lee SW, Lee YL, Lee YJ, et al. Enhanced antitumor effects by combination gene therapy using MDR1 gene shRNA and HSV1-tk in a xenograft mouse model. Cancer Lett 2010;291:83–9
   PubMed Web of Science ®Google Scholar
• Kim JE, Ahn BC, Hwang MH, et al. Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma. J Nucl Med 2011;52:1756–63
   PubMed Web of Science ®Google Scholar
• Kim HW, Kim JE, Hwang MH, et al. Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radioiodine pretreatment in breast cancer cells. PLoS One 2013;8:e70194
   PubMed Web of Science ®Google Scholar